South Dakota SB 163: address transparency in prescription drug pricing.

Status: Senate Reconsidered , Passed, YEAS 16, NAYS 19 S.J. 372 (as of 2022-02-23)

State: South Dakota · Session: 2022 · Bill: SB 163

Subjects: Food and Drugs, Insurance

Sponsors: Castleberry, Davis, Diedrich, Duba, Goodwin, Johnson (David), Miskimins, Olson, Perry, Reed, Reimer, Smith (Jamie), Smith (V. J.), Weisgram, Zikmund

View South Dakota SB 163 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.